Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Breaking & Recent News EOM Pharmaceutical Holdings Inc IMUC

EOM Pharmaceutical Holdings, Inc. is a clinical-stage pharmaceutical company. The Company is focused on developing novel drugs for patients suffering from debilitating and deadly diseases, including infectious diseases; autoimmune diseases including rheumatoid arthritis; and cachexia associated with acquired immune deficiency syndrome (AIDS) and cancer. It has two pipeline assets in their... see more

Recent & Breaking News (PINL:IMUC)

15 Biggest Mid-Day Losers For Friday

Benzinga.com  July 7, 2017

12 Biggest Mid-Day Gainers For Wednesday

Benzinga.com  July 5, 2017

ImmunoCellular Therapeutics Receives Notice from NYSE MKT for Noncompliance with Continued Listing Standards

PR Newswire June 29, 2017

JUNE 30 DEADLINE: Lundin Law PC Announces a Securities Class Action Lawsuit against ImmunoCellular Therapeutics, Ltd. and Encourages Investors with Losses to Contact the Firm

PR Newswire June 28, 2017

FRIDAY JUNE 30 DEADLINE: Khang & Khang LLP Announces a Securities Class Action Lawsuit against ImmunoCellular Therapeutics, Ltd. and Reminds Investors with Losses to Contact the Firm

GlobeNewswire June 27, 2017

The Klein Law Firm Reminds Investors of a Class Action Filed on Behalf of ImmunoCellular Therapeutics, Ltd. Shareholders and a Lead Plaintiff Deadline of June 30, 2017

GlobeNewswire June 27, 2017

FRIDAY DEADLINE: Lundin Law PC Announces a Securities Class Action Lawsuit against ImmunoCellular Therapeutics, Ltd. and Encourages Investors with Losses to Contact the Firm

GlobeNewswire June 26, 2017

IMUC INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving ImmunoCellular Therapeutics, Ltd. and a Lead Plaintiff Deadline of June 30, 2017

GlobeNewswire June 26, 2017

EQUITY ALERT: Levi & Korsinsky, LLP Reminds ImmunoCellular Therapeutics, Ltd. Shareholders of a Class Action Lawsuit and a Lead Plaintiff Deadline of June 30, 2017 – IMUC

GlobeNewswire June 23, 2017

ImmunoCellular Therapeutics Provides Update on Strategic Review and Decision to Suspend Further Patient Randomization for ICT-107 Phase 3 Trial

PR Newswire June 21, 2017

Law Offices of Howard G. Smith Reminds ImmunoCellular Therapeutics, Ltd. Investors of Pending Lawsuit and Upcoming Lead Plaintiff Deadline

Business Wire June 15, 2017

EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against ImmunoCellular Therapeutics, Ltd. - IMUC

PR Newswire June 14, 2017

June 30 Deadline Alert: GPM Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Synchronoss Technologies, Inc.

Business Wire June 14, 2017

ImmunoCellular Therapeutics to Present at Marcum MicroCap Conference on June 15, 2017

PR Newswire June 12, 2017

The Klein Law Firm Reminds Investors of a Class Action Filed on Behalf of Citizens Financial Group, Inc. Shareholders and a Lead Plaintiff Deadline of June 26, 2017

Business Wire June 6, 2017

ImmunoCellular Therapeutics Announces Data from ICT-121 Phase 1 Trial in Recurrent Glioblastoma at ASCO 2017

PR Newswire June 5, 2017

The Klein Law Firm Notifies Investors of a Class Action Filed on Behalf of Citizens Financial Group, Inc. Shareholders and a Lead Plaintiff Deadline of June 26, 2017

Business Wire June 5, 2017

IMUC ALERT: Rosen Law Firm Reminds ImmunoCellular Therapeutics, Ltd. of Important Deadline in Class Action – IMUC

GlobeNewswire June 2, 2017

IMMUNOCELLULAR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $500,000 in Immunocellular Therapeutics, Ltd. to Contact the Firm

Business Wire June 2, 2017

IMUC SHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving ImmunoCellular Therapeutics, Ltd. and a Lead Plaintiff Deadline of June 30, 2017

Business Wire June 2, 2017